The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AVROBIO INC | COM | 05455M100 | 11,707 | 829,121 | SH | OTR | 1 | 0 | 829,121 | 0 | |
| CELGENE CORP | COM | 151020104 | 11,106 | 111,844 | SH | OTR | 1 | 0 | 111,844 | 0 | |
| CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 471 | 235,701 | SH | OTR | 1 | 0 | 235,701 | 0 | |
| G1 THERAPEUTICS INC | COM | 3621LQ109 | 3,417 | 150,000 | SH | OTR | 1 | 0 | 150,000 | 0 | |
| HERON THERAPEUTICS INC | COM | 427746102 | 102,011 | 5,514,096 | SH | OTR | 1 | 0 | 5,514,096 | 0 | |
| IVERIC BIO INC | COM | 46583P102 | 672 | 600,000 | SH | OTR | 1 | 0 | 600,000 | 0 | |
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 43,462 | 4,938,893 | SH | OTR | 1 | 0 | 4,938,893 | 0 | |
| NUCANA PLC | SPONSORED ADR | 67022C106 | 3,620 | 500,000 | SH | OTR | 1 | 0 | 500,000 | 0 | |
| ODONATE THERAPEUTICS INC | COM | 676079106 | 366,379 | 14,075,269 | SH | OTR | 1 | 0 | 14,075,269 | 0 | |
| PROTHENA CORP PLC | SHS | G72800108 | 3,323 | 423,823 | SH | OTR | 1 | 0 | 423,823 | 0 | |
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 3,761 | 349,400 | SH | OTR | 1 | 0 | 349,400 | 0 | |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 34,548 | 2,965,485 | SH | OTR | 1 | 0 | 2,965,485 | 0 | |